Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 29:15:1367158.
doi: 10.3389/fendo.2024.1367158. eCollection 2024.

Statistical declarations versus scientific inferences and clinical judgments: the association of Glucagon-like peptide-1 receptor agonist use with the risk of biliary disease

David E Most  1
Affiliations

Statistical declarations versus scientific inferences and clinical judgments: the association of Glucagon-like peptide-1 receptor agonist use with the risk of biliary disease

David E Most. Front Endocrinol (Lausanne). .
No abstract available

Keywords: GLP-1; biliary disease; gastrointestinal adverse events; meta-analytic thinking; scientific inference and reasoning; statistical inference abuse.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

References

    1. Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA: J Am Med Assoc (2023) 330(18):1795–7. doi: 10.1001/jama.2023.19574 - DOI - PMC - PubMed
    1. Amrhein V, Greenland S, McShane B. Retire statistical significance. Nat (London) (2019) 567(7748):305–7. doi: 10.1038/d41586-019-00857-9 - DOI - PubMed
    1. Gelman A, Stern H. The difference between “Significant” and “Not significant” is not itself statistically significant. Am statistician (2006) 60(4):328–31. doi: 10.1198/000313006X152649 - DOI
    1. He L, Wang J, Ping F, Yang N, Huang J, Li Y, et al. . Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: A systematic review and meta-analysis of randomized clinical trials. JAMA Internal Med (2022) 182(5):513–9. doi: 10.1001/jamainternmed.2022.0338 - DOI - PMC - PubMed
    1. Wasserstein, Schirm AL, Lazar NA. Moving to a world beyond “p < 0.05”. Am Statistician (2019) 73(sup1):1–19. doi: 10.1080/00031305.2019.1583913 - DOI

Substances